TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers
2024 · Cell Death and Disease · 9 citations
https://doi.org/10.1038/s41419-024-06654-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
606
Citations
6
h-index
5
i10-index
Benjamin Southgate is an academic researcher from MRC Centre for Regenerative Medicine. The author has contributed to research in topics: Epigenetics and DNA Methylation & Pluripotent Stem Cells Research & CRISPR and Genetic Engineering. The author has an h-index of 6, co-authored 8 publications.
Click to start Chat